April Salama

DCI leadership presented the coveted DCI Superstar Achievement Awards in December and January.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

DCI researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire.

Brent Hanks, MD, PhD, and his lab team will trial a drug that targets the NLRP3 pathway, so as to unblock immunotherapy from working in melanoma patients.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

DCI's Melanoma (and advanced skin cancer) Disease Group expands Clinic 5-1 services to include dermatological cancer care for patients who require multidisciplinary care.

A decade since the first drug, an immunotherapy, was approved to treat metastatic melanoma, a leading clinician researcher goes head to head with melanoma brain metastasis.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Brent Hanks, MD, PhD, was named associate director of Translational Science for the Melanoma Disease Group this month.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Duke Cancer Institute will present more than 100 abstracts across multiple cancer types during the ASCO20 Virtual Scientific Program of the 2020 ASCO Annual Meeting.

The research team found a signaling pathway within melanoma and other cancers that thwart the functioning of anti-PD-1 checkpoint inhibitors.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

April Salama, MD, director of the Melanoma Disease Group, has joined the Duke Center for Brain and Spine Metastasis at DCI as associate medical director.

Duke alumnus Ross Bierkan has long supported his alma mater. But his support of melanoma research at Duke is motivated by personal experience.

Surgical oncologist and melanoma specialist Georgia Beasley, MD, MHSc, has been named co-director of Duke Cancer Institute’s Melanoma Disease Group.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

A willingness to try a clinical trial, plus his own brand of humor, are helping Tom Drew beat advanced cancer.It would be hard to find a more affable person.

LISTEN: Should Biobanking Come Under CLIA? (Mendelspod)  Features Shannon McCall, MD Polio virus treatment increased survival in patients with dea...